the core promoters and/or at enhancers. At the heart of this, there is a single transcription factor-or most likely an ensemble of several transcription factors-orchestrating the signaling output even before the ligand binds to its cognate receptor. Thus, understanding the molecular details of the key players in such switches-for example, the transcription factor Su(H) bound to its cofactor Hairless-is the eye-opener for designing mutants that allow for differentiation between activating and repressing mechanisms by changing individual amino acids. As an excellent example, this has been done in the study by Yuan et al. using the power of crystallography together with Drosophila genetics, which is particularly well-studied in regard to Notch signaling.
The Notch Transcriptional Activator Complex
In order to understand molecular mechanisms of biological processes, crystal structures are extremely insightful. Table 1 summarizes the structures that contain CSL-mediated transcription complexes. Historically, the mammalian transcription factor CSL (also known as recognition binding protein of Jκ [RBP-J or RBP-Jκ]) was discovered by Honjo and colleagues in the 1990s [5] and later was revealed to be the mammalian ortholog of Su(H) from Drosophila [6] . The original CSL-DNA complex structure showed that CSL is a distant relative of the Rel Fig 1. CSL functions as a molecular switch by binding either to corepressors or coactivators: Without an active Notch signal ("OFF"), CSL recruits corepressor complexes. H3K4 Demethylase (KDM) and HDAC activity erase the active chromatin marks H3K4me3 and H3K27ac, establishing a repressed chromatin state (left). After nuclear translocation, NICD (blue) interacts with CSL, recruiting a coactivator complex (right). H3K4-methyltransferase and histone acetyltransferase (HAT) activity establish the active chromatin marks H3K4me3 and H3K27ac, setting the chromatin in a transcriptional active state ("ON"). homology-containing transcription factor family [7] . The structure clearly shows that CSL is composed of three domains: N-terminal domain (NTD), β-trefoil domain (BTD), and C-terminal domain (CTD) [7] [8] [9] . The NTD and BTD domains are involved in DNA binding. Subsequently, two landmark studies determined the structure of the Notch activator complex, comprising CSL, a small N-terminal peptide of MAM, and the RAM (RBP-J associated molecule) and ANK (ankyrin repeats) domains of NICD. Importantly, as depicted in Fig 2A and described in [10, 11] , the RAM domain of NICD interacts with the BTD of CSL, whereas MAM is sandwiched between the surface formed between the CTD and ANK. This macromolecular assembly is supported by experiments demonstrating that the~70 amino acids of MAM seen in the structure are sufficient to block transcription of Notch target genes in a dominant-negative manner [12] .
The CSL [Su(H)] Transcriptional Repressor Complex
Like the Notch locus itself, the Hairless (H) locus was discovered in 1923 by Bridges and Morgan as a haploinsufficient mutation in Drosophila (reviewed in [16] ). The genetic interactions demonstrated that H antagonizes Notch signaling in a dose-dependent manner. Considering all the known interaction partners for CSL, H binds to Su(H) with the highest affinity (Kd = 2 nM) [4, 17] . The Su(H)-interaction domain of H on its own is an unstructured random coil. After binding to the CTD of Su(H), H assumes a β-hairpin conformation (see Fig 2C and the manuscript in this issue [4] ). Surprisingly, H interacts with specific side chains within the hydrophobic core of the Su(H)-CTD that are not exposed to the surface in the unbound structure of Su(H) [4] . The CTD of Su(H) is composed of a seven-stranded immunoglobulin (Ig)-fold (two β-sheets composed of three and four β-strands). This Ig-fold shows dramatic conformational changes when bound to H. H is sandwiched between the two β-sheets that compose the CTD, which is a hitherto completely new and unique interaction mode for Ig-folds. The conformational changes within the CTD block the CTD-NICD interaction and explain why binding of NICD and H are mutually exclusive. Based on their structural data, Yuan and colleagues designed specific point mutations within the CTD of Su(H), which lost H binding capacity but still was able to bind to NICD. In D. melanogaster in vivo experiments, using Notch-dependent wing and eye development as a readout, they could finally show that these Su(H) mutants have lost their corepressor activities but preserved their coactivator activity. These data highlight the importance of using Drosophila as a model system. Considering the structure by Yuan et al. [4] in a broader context, the repressor structure also suggests that the on-and off-rates of the Su(H)/H corepressor complex are slow; this is in contrast to CSL/NICD/MAM coactivator. To date, a pulse of Notch signaling was mainly considered to be an interplay between receptor-ligand binding, posttranslational modifications of the NICD, and, ultimately, turnover of the coactivator complex [18] . Now, the rate of Su(H)-corepressors should be included in such considerations. Furthermore, the repressive mechanism at Notch target genes could also be a general theme used for other signaling pathways, like Wnt and Hedgehog signaling. For Hedgehog signaling, Gli is the central transcription factor, but the mechanisms of cofactor recruitment remain to be elucidated. For Wnt signaling, the central transcription factor is T cell factor (TCF)/Lymphoid enhancer binding factor (Lef), which in the absence of a Wnt signal binds promoters and recruits HDAC-containing corepressor complexes (reviewed in [19] ).
The CSL-Repressor Complex Configures Chromatin for the Notch Response
Regarding the repressive mechanism mediated by the CSL-repressor complex, H recruits Groucho and an HDAC-containing C-terminal binding protein (CtBP) corepressor complex [20] [21] [22] . The same is true for the human CSL-repressor complex containing HDACs and CtBP [23] (reviewed in [24] ). Surprisingly, there is no direct Hairless homolog in mammals, but the functional homolog suggested by us and others is SHARP (also known as Spen or MINT). SHARP directly binds CSL, and intriguingly, it also interacts with the CTD of CSL similarly to Hairless [25] .
Biochemical experiments from several laboratories implicated not only HDACs but also H3K4 demethylases as direct CSL-associated factors both in Drosophila [26] [27] [28] and mammals [28, 29] . Recently, we added the counteracting H3K4 methyltransferase KMT2D as a novel component of the CSL coregulator complex [30] . All of these chromatin modifications are not only directed by a single transcription factor but most likely by a set of few transcription factors. The created balance between positive and negative histone marks sets the stage for the incoming extracellular signal.
The structure-based point mutants described in [4] gives us insights into how precisely mutagenesis can be used to dissect function of pivotal transcription complexes. Clearly, the next big step in the field is to solve the structure of human CSL/SHARP corepressor complex. Since CSL has been shown to function as a tumor suppressor [31] , it might be feasible to design therapeutics that disrupt CSL-corepressor interactions in order to weakly activate Notch signaling, which may be beneficial in some disease settings.
Genome-wide studies using anti-CSL and anti-NICD antibodies have been important to define bona fide Notch target genes [32] [33] [34] in cells. Further analysis suggests that CSL occupancy depends on the presence of an active Notch signal [35, 36] , questioning the whole concept of CSL-bound corepressors. On the other hand, there are reports showing that deletion of CSL leads to derepression of some Notch target genes, both in Drosophila [20, 37, 38] and mammals [39] . Certainly, CSL knockout followed by rescue with wildtype or mutant CSL will be key to addressing this open question, leading the way forward to dissect individual functions of this central transcription factor. It will also be interesting to dissect the chromatin landscape at Notch target genes in the presence or absence of CSL or of individual corepressors.
In mammals, the situation of the CSL corepressor-namely SHARP [40, 41] , KyoT2 [42] , and RITA [43] complex-is more complex, and the molecular mechanisms need to be further elucidated in the future. Clearly, as a next step, the cocrystal structures of CSL/SHARP and CSL/RITA would be a big move forward. (Fig 2D) . This will unravel the molecular mechanisms whether or not the RAM-type or Hairless-type of binding to transcription factor CSL is the predominant one or if alternative types of interactions do exist.
